Accueil   Diary - News   All news CarThera to present update on SonoCloud-9 clinical study at upcoming SNO Congress in Phoenix, Arizona

CarThera to present update on SonoCloud-9 clinical study at upcoming SNO Congress in Phoenix, Arizona

 

 

Paris, France, November 14, 2019 – CarThera, a French company that designs and develops innovative ultrasound-based medical devices to treat brain disorders, will attend the the Society for Neuro-Oncology’s (SNO) 24th Annual Meeting, in Phoenix, Arizona, November 20-24. Professor Alexandre Carpentier, founder of CarThera and neurosurgeon at Pitie Salpetriere Hospital (Paris, France), will be presenting an update on CarThera’s on-going work to develop the SonoCloud for treatment of brain tumors.

 


As the world’s largest neuro-oncology conference, the event attracts over 2,400 researchers and clinician scientists from more than 40 countries worldwide. CarThera will join delegates to share its own medical knowledge and gain insights on the future of neuro-oncology research and treatment.

 

 

Read the press release

 

 

 

 

 

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree